ArticleFrontiers in psychiatry2025
Thyroid dysfunction in elderly first-episode drug-naïve major depressive disorder patients with comorbid dyslipidemia: prevalence, clinical profile and associated factors.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Elderly major depressive disorder (MDD) patients often exhibit complex symptomatology and high rates of abnormal lipid metabolism (ALM), yet predictors of abnormal thyroid function in those with co-occurring lipid metabolism are not fully elucidated. This study aimed to investigate the relationship between thyroid function and ALM in first-episode, drug-naïve (FEDN) elderly MDD patients. Methods: 1,029 elderly FEDN MDD patients were enrolled. Demographics, lipid profile (TC, TG, LDL-C, HDL-C), thyroid parameters (TSH, FT3, FT4, TG-Ab, TPO-Ab), and symptom ratings (HAMD, HAMA, PANSS-positive) were assessed. Results: Prevalence of abnormal thyroid function was 69.0%. Compared with ALM patients without thyroid dysfunction, those affected had higher HAMD, HAMA, and PANSS-positive scores, more suicide attempts, severe anxiety, and psychotic symptoms (all P < 0.05). Logistic regression identified BMI (OR = 1.186), HAMD score (OR = 1.201), blood glucose (OR = 4.03), TC (OR = 1.683), and LDL-C (OR = 1.299) were independent associated factors for abnormal thyroid function in MDD patients with comorbid ALM(all P < 0.001). Conclusion: Abnormal thyroid function is highly prevalent in elderly FEDN MDD patients with ALM; clinical severity, glucose, and lipid levels contribute to this comorbidity. These findings suggest that elderly, first-episode MDD patients with dyslipidemia, particularly those with elevated BMI, high blood glucose, and severe depressive symptoms, should undergo routine screening for thyroid dysfunction to facilitate early intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.